VTRS Viatris Inc.

19.88USD-1.97%Mkt Cap: 22.79B USDP/E: —

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. …

Institutional holders20 on file

Key Statistics

Company
Market Cap22.79B USD
Enterprise Value34.36B USD
Revenue (TTM)14.73B USD
Gross Profit5.01B USD
Net Income (TTM)-3.51B USD
Revenue/Share12.75 USD
Last Price19.88 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees30.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.21
PEG3.69
EV/EBITDA7.85
EV/Revenue2.33
P/S1.55
P/B1.67
EPS (TTM)-0.53 USD
EPS (Forward)2.76 USD
52W Range
9.92088% of range21.20
52W High21.20 USD
52W Low9.920 USD
Profitability
Gross Margin35.06%
Oper. Margin11.49%
EBITDA Margin29.72%
Profit Margin-24.58%
ROE-23.89%
ROA-9.45%
ROIC0.87%
ROCE0.84%
Growth
Revenue Growth-0.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.32B USD
CapEx (TTM)465.10M USD
FCF Margin21.45%
FCF Yield13.86%
Net Debt11.57B USD
Net Debt/EBITDA2.64
Net Debt/FCF3.66
Balance Sheet
Debt/Equity1.00
Current Ratio1.55
Quick Ratio0.82
Book Value/Sh11.94 USD
Cash/Share1.75 USD
Dividends
Fwd Div Rate0.48 USD
Trail. Div Rate0.48 USD
Div. Yield2.37%
5Y Avg Yield3.97%
Payout Ratio960.00%
Ex-Div DateNov 23, 2026
Pay DateDec 16, 2026
Splits
Last Split3:2
Split DateOct 9, 2003
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.60 USD
Upside (mean)+8.7%
Target Range14.00 USD – 28.00 USD
14.00+8.7% to mean28.00
# Analysts10
Ownership
Shares Out.1.15B
Float1.14B
Insiders0.32%
Institutions92.83%
Short Interest
Short Ratio4.0d
Short % Float3.08%
Short % Out.3.07%
Shares Short35.24M
Short (prev mo.)42.04M
Technical
SMA 5018.34 (+8.4%)
SMA 20016.35 (+21.6%)
Beta0.87
S&P 52W Chg12.00%
Avg Vol (30d)9.35M
Avg Vol (10d)11.94M
Technical Indicators
RSI (14)55.5
MACD0.6372
MACD Signal0.6741
MACD Hist.-0.0369
BB Upper21.58 USD
BB Middle19.65 USD
BB Lower17.71 USD
BB Width19.72%
ATR (14)0.5438 USD
Vol Ratio (20d)0.98x

About Viatris (NASDAQ: VTRS)

›

Viatris (NASDAQ: VTRS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 30,000 employees.

The shares were at 19.88 USD on 19 November 2026, up 90.1% over 52 weeks. Its 52-week range is 9.920 USD to 21.20 USD: the price is 6.2% below the high and 100.4% above the low.

Its market capitalisation is 22.79B USD. It pays a dividend yielding 2.37%, against a median of 1.88% among the dividend payers in that peer group.

Viatris reports return on equity of -23.9%, an operating margin of 11.5% and flat revenue year over year.

Its debt exceeds its cash by 11.57B USD, a debt-to-equity ratio of 1.00. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 21.60 USD is 8.7% above the current price. The next earnings report is expected on 25 February 2027.